145 related articles for article (PubMed ID: 37187289)
1. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
Jones D; Spirito A; Sartori S; Smith KF; Pivato CA; Chiarito M; Cao D; Nicolas J; Beerkens F; Edens M; Pileggi B; Sen A; Zhang Z; Vogel B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
J Cardiol; 2023 Sep; 82(3):179-185. PubMed ID: 37187289
[TBL] [Abstract][Full Text] [Related]
2. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Chen H; Spirito A; Sartori S; Nicolas J; Cao D; Zhang Z; Baber U; Kamaleldin K; Guthrie J; Vogel B; Sweeny J; Krishnan P; Sharma SK; Kini A; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2023 Feb; 101(3):511-519. PubMed ID: 36691863
[TBL] [Abstract][Full Text] [Related]
3. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
[TBL] [Abstract][Full Text] [Related]
5. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
Bangalore S; Abhaichand R; Mullasari A; Jain R; Chand RKP; Arambam P; Kaul U
Cardiovasc Revasc Med; 2019 Dec; 20(12):1075-1080. PubMed ID: 31036397
[TBL] [Abstract][Full Text] [Related]
6. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
[TBL] [Abstract][Full Text] [Related]
7. Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease.
Tokuda K; Tanaka A; Tobe A; Shirai Y; Kurobe M; Kubota Y; Kunieda T; Miyazaki T; Mizutani K; Furusawa K; Ishii H; Murohara T
J Atheroscler Thromb; 2023 Nov; 30(11):1635-1643. PubMed ID: 36908149
[TBL] [Abstract][Full Text] [Related]
8. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
9. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
[TBL] [Abstract][Full Text] [Related]
10. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
[TBL] [Abstract][Full Text] [Related]
11. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention.
Liu Y; Jia SD; Yao Y; Tang XF; Xu N; Jiang L; Gao Z; Chen J; Yang YJ; Gao RL; Xu B; Yuan JQ
J Cardiol; 2020 Jan; 75(1):60-65. PubMed ID: 31416781
[TBL] [Abstract][Full Text] [Related]
12. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
[TBL] [Abstract][Full Text] [Related]
13. Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
Circ J; 2016 Dec; 81(1):90-95. PubMed ID: 27867158
[TBL] [Abstract][Full Text] [Related]
14. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention].
Chen RZ; Liu C; Zhou P; Tan Y; Sheng ZX; Li JN; Zhou JY; Wu Y; Yang YM; Song L; Zhao HJ; Yan HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):359-366. PubMed ID: 32450651
[No Abstract] [Full Text] [Related]
15. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
[TBL] [Abstract][Full Text] [Related]
16. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
[TBL] [Abstract][Full Text] [Related]
18. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
Kosmidou I; Redfors B; Chen S; Crowley A; Lembo NJ; Karmpaliotis D; Brown WM; Maupas E; Durrleman N; Shah A; Reardon MJ; Dressler O; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Am Heart J; 2019 Apr; 210():49-57. PubMed ID: 30738244
[TBL] [Abstract][Full Text] [Related]
20. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Circ J; 2017 Aug; 81(9):1293-1300. PubMed ID: 28428450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]